<PAGE>
EXHIBIT 99.3
[LOGO]
SYNAVANT INC.
3445 PEACHTREE RD. NE, SUITE 1400
ATLANTA, GEORGIA 30326
August [ ], 2000
DEAR STOCKHOLDER:
We are very pleased that you will soon be a stockholder of Synavant Inc.
("Synavant"). Synavant is the global market leader in customized Pharmaceutical
Relationship Management ("PRM") solutions and interactive marketing services,
helping pharmaceutical companies achieve maximum return on their sales and
marketing investment, providing e-business applications software to the
pharmaceutical, biotechnology and healthcare industries. Synavant's vision is to
accelerate the adoption of advances in healthcare around the world. Speed to
market is a critical success factor for Synavant's clients. By drawing together
the expertise within Synavant and its partners, Synavant is able to help its
clients get their products and services to market more quickly, more effectively
and with a greater return on investment.
As part of IMS Health Incorporated ("IMS HEALTH"), the Synavant businesses
have been known for providing outstanding service levels and having in-depth
knowledge of the pharmaceutical market. As an independent company, our highest
priority will be to integrate the unique industry leading capabilities of the
Clark-O'Neill and IMS Health Strategic Technologies businesses to provide high
value knowledge-based solutions to the biopharmaceutical industry and healthcare
system that optimize the development, promotion and delivery of healthcare
products and services globally.
Synavant Inc. began operating earlier this year, when IMS HEALTH combined
its Strategic Technologies and Clark-O'Neill businesses into a single unit,
which is now being spun off as a separately traded company. We believe that the
separation of our businesses from our corporate parent, IMS HEALTH, will provide
us with greater managerial, operational and financial focus to respond to market
conditions in our business environment. For the first time, we will have the
ability to offer our employees incentive opportunities linked to Synavant's
performance as a stand-alone company, which we believe will aid our efforts to
enhance recruitment and performance.
Holders of IMS HEALTH's common stock as of the record date of July 28, 2000
will receive one share of Synavant common stock for every 20 shares of IMS
HEALTH. The distribution of those shares will occur on or about August 31, 2000.
The distribution should qualify as a tax-free transaction both to IMS HEALTH and
to IMS HEALTH stockholders for U.S. federal income tax purposes, except for any
tax payable because of any cash IMS HEALTH stockholders received in lieu of
fractional shares of Synavant common stock. For information regarding the tax
basis of your new shares, we encourage you to contact the distribution agent,
EquiServe Trust Company, at Mail Suite 4694, P.O. Box 2536, Jersey City, New
Jersey 06303-2536.
Synavant has applied for listing of its shares on the Nasdaq National Market
under the symbol "SNVT".
Our board, management and employees are excited about our future as an
independent company and we look forward to your support and participation in our
success.
Sincerely,
Wayne P. Yetter
Chairman and Chief Executive Officer
Synavant Inc.
